UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Clinical gastroenterology and hepatology, 2021-01, Vol.19 (1), p.46-60.e8

2021

Volltextzugriff (PDF)

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence

Therapeutic Advances in Gastroenterology, 2018-01, Vol.11, p.1756284818786108-1756284818786108

2018

Volltextzugriff (PDF)

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005788-e1005788

2016

Volltextzugriff (PDF)

Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy

Journal of Virology, 2011-03, Vol.85 (5), p.2416-2428

2011

Volltextzugriff (PDF)

Monotherapy versus combination therapy for the treatment of chronic hepatitis B

Expert opinion on investigational drugs, 2009-11, Vol.18 (11), p.1655-1666

2009

Volltextzugriff (PDF)

Review of the neurological manifestations of hepatitis E infection

Annals of hepatology, 2012-09, Vol.11 (5), p.618-622

2012

Volltextzugriff (PDF)

Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

Hepatology (Baltimore, Md.), 2020-07, Vol.72 (1), p.42-57

2020

Volltextzugriff (PDF)

Review article: novel biomarkers in hepatitis B infection

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (5), p.760-776

2022

Volltextzugriff (PDF)

A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV ‘cure’

Journal of hepatology, 2022-07, Vol.77 (1), p.245-248

2022

Volltextzugriff (PDF)

Global elimination of hepatitis C: a warning from the data

The lancet. Gastroenterology & hepatology, 2022-05, Vol.7 (5), p.380-381

2022

Volltextzugriff (PDF)

Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population

Journal of virological methods, 2012-09, Vol.184 (1-2), p.55-62

2012

Volltextzugriff (PDF)

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

Journal of hepatology, 2020-06, Vol.72 (6), p.1097-1104

2020

Volltextzugriff (PDF)

Validation of an internal hepatitis D virus DNA quantitative assay: developing assay suitable for global clinical application and clinical trials assessment

Journal of hepatology, 2022-07, Vol.77, p.S280

2022

Volltextzugriff (PDF)

The serum markers of cccDNA transcriptional activity have a role in predicting long-term outcomes in children with perinatally acquired HBV infection

Journal of hepatology, 2022-07, Vol.77, p.S287

2022

Volltextzugriff (PDF)

Hepatitis delta: recent advances and future therapies

Future virology, 2024-03, Vol.19 (5), p.215-223

2024

Volltextzugriff (PDF)

FRI-399 Hepatitis B core-related antigen is a good predictor for high risk of mother to child transmission in chronic hepatitis B

Journal of hepatology, 2024-06, Vol.80, p.S775-S775

2024

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2021-02, Vol.73 (2), p.870-871

2021

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2021-02, Vol.73 (2), p.870-871

2021

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2021-02, Vol.73 (2), p.870-871

2021

Volltextzugriff (PDF)

P131 Screening for HDV infection in newly diagnosed HBsAg positive patients: comparison of testing between specialist hepatology laboratory vs. community virology laboratory in South East London

Gut, 2023-09, Vol.72 (Suppl 3), p.A101-A101

2023

Volltextzugriff (PDF)

P128 A composite score consisting of both cccDNA transcriptional activity biomarkers and immunological markers in serum refines HBeAg-negative chronic hepatitis B phases

Gut, 2023-09, Vol.72 (Suppl 3), p.A98-A99

2023

Volltextzugriff (PDF)

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study

The Journal of infection, 2020-08, Vol.81 (2), p.282-288

2020

Volltextzugriff (PDF)

WED-144 - HDV genotypes have an impact on pegylated interferon therapy response and long-term liver disease related outcomes

Journal of hepatology, 2023-06, Vol.78, p.S1081-S1082

2023

Volltextzugriff (PDF)

FRI-161 - Hepatitis D infection in a HBsAg cohorts referred from specialist liver clinics vs. reflex community referred patients in South East London

Journal of hepatology, 2023-06, Vol.78, p.S905-S906

2023

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(123)

Sprache

Englisch
(123)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(48)
Gastroenterology & Hepatology
(27)
Humans
(27)
Hepatitis B
(18)
Female
(13)
Antiviral Agents - Therapeutic Use
(12)
Hepatitis
(12)
Male
(12)
Patients
(12)
Antiviral Agents
(11)
Deoxyribonucleic Acid
(11)
Dna
(11)
Hepatitis B Virus - Genetics
(11)
Hepatitis B, Chronic - Drug Therapy
(10)
Rna
(10)
Adult
(9)
Hepatitis B Surface Antigen
(9)
Infectious Diseases
(9)
Interferon
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo

Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy

Monotherapy versus combination therapy for the treatment of chronic hepatitis B

Review of the neurological manifestations of hepatitis E infection

Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study

Review article: novel biomarkers in hepatitis B infection

A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV ‘cure’

Global elimination of hepatitis C: a warning from the data

Development and validation of an efficient in-house real-time reverse transcription polymerase chain reaction assay for the quantitative detection of serum hepatitis delta virus RNA in a diverse South London population

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

Validation of an internal hepatitis D virus DNA quantitative assay: developing assay suitable for global clinical application and clinical trials assessment

The serum markers of cccDNA transcriptional activity have a role in predicting long-term outcomes in children with perinatally acquired HBV infection

Hepatitis delta: recent advances and future therapies

FRI-399 Hepatitis B core-related antigen is a good predictor for high risk of mother to child transmission in chronic hepatitis B

Reply

Reply

Reply

P131 Screening for HDV infection in newly diagnosed HBsAg positive patients: comparison of testing between specialist hepatology laboratory vs. community virology laboratory in South East London

P128 A composite score consisting of both cccDNA transcriptional activity biomarkers and immunological markers in serum refines HBeAg-negative chronic hepatitis B phases

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study

WED-144 - HDV genotypes have an impact on pegylated interferon therapy response and long-term liver disease related outcomes

FRI-161 - Hepatitis D infection in a HBsAg cohorts referred from specialist liver clinics vs. reflex community referred patients in South East London

Suchergebnisse filtern